Efficacy of a Quadruple Immunosuppressor Regimen With mTOR Inhibitors in Sensitized Kidney Transplant Patients

PHASE4RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

August 31, 2024

Study Completion Date

July 31, 2025

Conditions
Disorder Related to Renal Transplantation
Interventions
DRUG

Everolimus

mTORi added as the fourth maintenance immunosuppressive drug in recipients

DRUG

standard maintenance immunosuppression

standard maintenance immunosuppression: tacrolimus, mycophenolate, prednisone

Trial Locations (1)

05403-900

RECRUITING

Renal Transplantation Service, São Paulo

All Listed Sponsors
collaborator

Carlucci G Ventura

UNKNOWN

collaborator

Daniel R Salomon

UNKNOWN

collaborator

Fabiana Agena

UNKNOWN

collaborator

Flavio J de Paula

UNKNOWN

collaborator

Francine B Lemos

UNKNOWN

collaborator

Gislene Bezerra

UNKNOWN

collaborator

Helcio Rodrigues

UNKNOWN

collaborator

Maria da Luz Fernandes

UNKNOWN

collaborator

Nelson Zocoler Galante

UNKNOWN

collaborator

Noemia B de Lima

UNKNOWN

collaborator

Paschoalina Romano

UNKNOWN

collaborator

Patricia S Souza

UNKNOWN

collaborator

Vivian Onuchic

UNKNOWN

collaborator

Elias David Neto

UNKNOWN

lead

University of Sao Paulo General Hospital

OTHER